A T McLellan
Overview
Explore the profile of A T McLellan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
216
Citations
6900
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McLellan A
Exp Clin Psychopharmacol
. 2001 Aug;
9(1):29-32; discussion 35-9.
PMID: 11519631
The power of positively reinforced contingency management procedures has been definitively proven in the drug abuse field-even among the most severely affected clients. This study by K. Silverman, D. Svikis,...
2.
Carise D, McLellan A, Cacciola J, Love M, Cook T, Bovasso G, et al.
J Subst Abuse Treat
. 2001 Aug;
20(3):239-44.
PMID: 11516594
The Addiction Severity Index (ASI) has become one of the most widely used instruments in the addictions field. As a result of its wide popularity, there are multiple versions of...
3.
Can the Treatment Services Review be used to estimate the costs of addiction and ancillary services?
French M, Roebuck M, McLellan A, Sindelar J
J Subst Abuse
. 2001 Jul;
12(4):341-61.
PMID: 11452838
Purpose: The economic costs of addiction treatment and ancillary services are of great interest to substance abuse treatment providers, researchers, and policymakers. This paper examines whether a widely used treatment...
4.
Marlowe D, Merikle E, Kirby K, Festinger D, McLellan A
Psychol Addict Behav
. 2001 Jun;
15(2):97-108.
PMID: 11419236
Motivational assessment instruments typically measure clients' attributions about their readiness to change problem behaviors. They do not indicate why a client may be motivated to change, or provide guidance on...
5.
Weinrieb R, Van Horn D, McLellan A, Volpicelli J, Calarco J, Lucey M
J Addict Dis
. 2001 Apr;
20(2):105-19.
PMID: 11318394
Alcohol misuse is the second most common indication for liver transplantation in the United States. Our post-transplant alcoholism treatment trial suggested that current interventions might not be transferable to liver...
6.
Weinrieb R, Van Horn D, McLellan A, Alterman A, Calarco J, OBrien C, et al.
Psychosomatics
. 2001 Mar;
42(2):110-6.
PMID: 11239123
Alcoholic liver disease is the second most common indication for liver transplantation in the United States. The lack of alcoholism treatment studies led us to study motivational enhancement therapy (MET)...
7.
French M, Salome H, Krupski A, McKay J, Donovan D, McLellan A, et al.
Eval Rev
. 2001 Jan;
24(6):609-34.
PMID: 11151519
A benefit-cost analysis of full continuum (FC) and partial continuum (PC) care was conducted on a sample of substance abusers from the State of Washington. Economic benefits were derived from...
8.
Carise D, McLellan A, Gifford L
Subst Use Misuse
. 2001 Jan;
35(12-14):1797-818.
PMID: 11138708
This paper reviews the current literature on the definition and classification of drug and alcohol user treatment "programs," and provides a rationale for our approach to measuring the treatment programs...
9.
Dennis M, Perl H, Huebner R, McLellan A
Addiction
. 2001 Jan;
95 Suppl 3:S281-308.
PMID: 11132359
While some aspects of addiction can be studied in laboratory or controlled settings, the study of long-term recovery management and the health services that support it requires going out into...
10.
Weinrieb R, Van Horn D, McLellan A, Lucey M
Liver Transpl
. 2000 Nov;
6(6):769-76.
PMID: 11084066
Few studies have examined the value of treating alcohol addiction either before or after liver transplantation. Nevertheless, most liver transplant programs and many insurance companies require 6 months to 1...